Chemoinformaics analysis of Swietenocoumarin I
| Molecular Weight | 346.423 | nRot | 6 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 1 |
| Exact Molecular Weight | 346.178 | nRing | 2 |
| Solubility: LogS | -5.216 | nHRing | 1 |
| Solubility: LogP | 5.427 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 11 |
| nHA | 5 | APOL | 54.7466 |
| nHD | 2 | BPOL | 30.4234 |
| QED | 0.353 |
| Synth | 1.869 |
| Natural Product Likeliness | 0.431 |
| NR-PPAR-gamma | 0.25 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.066 |
| Pgp-sub | 0.014 |
| HIA | 0.005 |
| CACO-2 | -4.77 |
| MDCK | 0.000024 |
| BBB | 0.471 |
| PPB | 0.955633 |
| VDSS | 0.842 |
| FU | 0.0209831 |
| CYP1A2-inh | 0.69 |
| CYP1A2-sub | 0.199 |
| CYP2c19-inh | 0.391 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.286 |
| CYP2c9-sub | 0.931 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.055 |
| CYP3a4-inh | 0.318 |
| CYP3a4-sub | 0.056 |
| CL | 6.563 |
| T12 | 0.521 |
| hERG | 0.143 |
| Ames | 0.005 |
| ROA | 0.018 |
| SkinSen | 0.955 |
| Carcinogencity | 0.081 |
| EI | 0.958 |
| Respiratory | 0.655 |
| NR-Aromatase | 0.088 |
| Antiviral | No |
| Prediction | 0.532538 |